Oramed Pharmaceuticals Inc.

ORMP·NASDAQ·$4.04Share Price as of 11/2·$165MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/19/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report09/17/26 8-KCurrent report06/30/26 8-KCurrent report03/31/26 8-KCurrent report02/20/26 8-KCurrent report01/14/26

Prospectuses and Registrations

S-8Registration of securities for employees08/21/25 424B5Prospectus supplement03/18/24 S-8Registration of securities for employees07/12/22 424B5Prospectus supplement11/04/21 424B5Prospectus supplement09/01/21

Proxies

DEF 14ADefinitive proxy08/03/26 DEFA14AAdditional proxy materials08/03/26 DEF 14ADefinitive proxy07/16/25 DEF 14ADefinitive proxy06/20/24 DEF 14ADefinitive proxy05/31/23

Ownership

Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26 144Proposed sale of securities10/01/26 144Proposed sale of securities10/01/26 Form 4Insider transaction09/25/26

Other

ARSAnnual report to shareholders08/03/26 NT 10-QLate filing notification (10-Q)05/15/26 8-A12B8-A12B11/17/25 ARSAnnual report to shareholders07/16/25 ARSAnnual report to shareholders06/20/24